Under the terms of the new Contract Manufacturing Agreement, effective as of March 17, 2025, AVITA Medical is to manufacture PermeaDerm at its state-of-the-art manufacturing facility in Ventura, ...

DelveInsight's "VITRAKVI Market Size, Forecast, and Market Insight Report" highlights the details around VITRAKVI, a TRK, ...

Claire Bryan, education reporter at The Seattle Times, coauthored a recent investigation looking at surveillance tech in schools. She found that most devices were tracking students 24/7. Back when ...

The first week of the NFL's free agency period is in the books with the legal tampering period beginning on Monday and then Wednesday marking the official start of the new league year. We've seen ...

NFL free agency officially began with the new league year kicking off at 4 p.m. ET on Wednesday. There were plenty of moves made during the legal tampering period on Monday and Tuesday, but those ...

VITRAKVI has strong market potential as a first-in-class TRK inhibitor for patients with NTRK gene fusion-positive cancers, regardless of tumor type. The growing adoption of precision oncology ...

Today’s health and medical science professionals need to be proficient in their chosen field, committed to helping others, and driven to take on the unique and ever-changing challenges facing modern ...

Accelerated aging in breast cancer survivors is linked to treatments and tumor characteristics, with implications for long-term care and quality of life. Researchers determine the role of dietary ...

It's time for researchers to reconsider the current paradigm of cancer as a genetic disease, argued Sui Huang from the Institute for Systems Biology, USA, and colleagues in a new essay published ...

You can now play an even larger range of puzzles on our site, every weekday and now also every Saturday. Check out our brand new puzzles below, from Hangman to Add Up and even a Jigsaw. Of course ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...